Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - OTHER CURRENT LIABILITIES
Other Current Liabilities EBS - Emergent BioSolutions Inc.
125 M
LAST VALUE
-23.36%
2 YEAR CAGR
5.82%
5 YEAR CAGR
16.47%
10 YEAR CAGR